Follow
Jonathan Howlett
Jonathan Howlett
Clinical Professor of Medicine
Verified email at ucalgary.ca
Title
Cited by
Cited by
Year
Dapagliflozin in patients with heart failure and reduced ejection fraction
JJV McMurray, SD Solomon, SE Inzucchi, L Køber, MN Kosiborod, ...
New England Journal of Medicine 381 (21), 1995-2008, 2019
55312019
HFSA 2010 comprehensive heart failure practice guideline.
J Lindenfeld, NM Albert, JP Boehmer, SP Collins, JA Ezekowitz, ...
Journal of cardiac failure 16 (6), e1-194, 2010
2608*2010
Effect of nesiritide in patients with acute decompensated heart failure
CM O'Connor, RC Starling, AF Hernandez, PW Armstrong, K Dickstein, ...
New England Journal of Medicine 365 (1), 32-43, 2011
14332011
Effects of exercise training on health status in patients with chronic heart failure: HF-ACTION randomized controlled trial
KE Flynn, IL Piña, DJ Whellan, LI Lin, JA Blumenthal, SJ Ellis, LJ Fine, ...
Jama 301 (14), 1451-1459, 2009
9082009
2017 Comprehensive update of the Canadian Cardiovascular Society guidelines for the management of heart failure
JA Ezekowitz, E O'Meara, MA McDonald, H Abrams, M Chan, ...
Canadian Journal of Cardiology 33 (11), 1342-1433, 2017
7862017
Hypertension Canada’s 2018 guidelines for diagnosis, risk assessment, prevention, and treatment of hypertension in adults and children
KA Nerenberg, KB Zarnke, AA Leung, K Dasgupta, S Butalia, K McBrien, ...
Canadian Journal of Cardiology 34 (5), 506-525, 2018
6952018
HRS/EHRA expert consensus on the monitoring of cardiovascular implantable electronic devices (CIEDs): description of techniques, indications, personnel, frequency and ethical …
BL Wilkoff, A Auricchio, J Brugada, M Cowie, KA Ellenbogen, AM Gillis, ...
Europace 10 (6), 707-725, 2008
6132008
Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006: diagnosis and management
JMO Arnold, P Liu, C Demers, P Dorian, N Giannetti, H Haddad, ...
Canadian Journal of Cardiology 22 (1), 23-45, 2006
5762006
Hypertension Canada's 2016 Canadian hypertension education program guidelines for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of …
AA Leung, K Nerenberg, SS Daskalopoulou, K McBrien, KB Zarnke, ...
Canadian Journal of Cardiology 32 (5), 569-588, 2016
5372016
Cardiac myosin activation with omecamtiv mecarbil in systolic heart failure
JR Teerlink, R Diaz, GM Felker, JJV McMurray, M Metra, SD Solomon, ...
New England Journal of Medicine 384 (2), 105-116, 2021
5182021
The 2015 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension
SS Daskalopoulou, DM Rabi, KB Zarnke, K Dasgupta, K Nerenberg, ...
Canadian Journal of Cardiology 31 (5), 549-568, 2015
4872015
Hypertension Canada’s 2020 comprehensive guidelines for the prevention, diagnosis, risk assessment, and treatment of hypertension in adults and children
DM Rabi, KA McBrien, R Sapir-Pichhadze, M Nakhla, SB Ahmed, ...
Canadian Journal of Cardiology 36 (5), 596-624, 2020
4672020
Effect of dapagliflozin on worsening heart failure and cardiovascular death in patients with heart failure with and without diabetes
MC Petrie, S Verma, KF Docherty, SE Inzucchi, I Anand, J Bělohlávek, ...
Jama 323 (14), 1353-1368, 2020
4562020
N-terminal pro–B-type natriuretic peptide testing improves the management of patients with suspected acute heart failure: primary results of the Canadian prospective randomized …
GW Moe, J Howlett, JL Januzzi, H Zowall
Circulation 115 (24), 3103-3110, 2007
428*2007
Hypertension Canada's 2017 guidelines for diagnosis, risk assessment, prevention, and treatment of hypertension in adults
AA Leung, SS Daskalopoulou, K Dasgupta, K McBrien, S Butalia, ...
Canadian Journal of Cardiology 33 (5), 557-576, 2017
4182017
The 2014 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension
K Dasgupta, RR Quinn, KB Zarnke, DM Rabi, P Ravani, ...
Canadian Journal of Cardiology 30 (5), 485-501, 2014
3742014
Effects of exercise training on depressive symptoms in patients with chronic heart failure: the HF-ACTION randomized trial
JA Blumenthal, MA Babyak, C O’Connor, S Keteyian, J Landzberg, ...
Jama 308 (5), 465-474, 2012
3622012
A trial to evaluate the effect of the sodium–glucose co‐transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left …
JJV McMurray, DL DeMets, SE Inzucchi, L Køber, MN Kosiborod, ...
European journal of heart failure 21 (5), 665-675, 2019
3242019
The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2–therapy
DG Hackam, NA Khan, BR Hemmelgarn, SW Rabkin, RM Touyz, ...
Canadian Journal of Cardiology 26 (5), 249-258, 2010
3132010
The 2013 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension
DG Hackam, RR Quinn, P Ravani, DM Rabi, K Dasgupta, ...
Canadian Journal of Cardiology 29 (5), 528-542, 2013
2992013
The system can't perform the operation now. Try again later.
Articles 1–20